Edition:
United States

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

1.98USD
21 Sep 2018
Change (% chg)

$0.08 (+4.21%)
Prev Close
$1.90
Open
$1.92
Day's High
$1.98
Day's Low
$1.92
Volume
1,669
Avg. Vol
3,282
52-wk High
$4.21
52-wk Low
$1.76

Chart for

About

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product... (more)
No analyst recommendations are available for .

Overall

Beta: -0.68
Market Cap(Mil.): $22.37
Shares Outstanding(Mil.): 11.30
Dividend: --
Yield (%): --

Financials

  CBLI.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -0.40 -- --
ROI: -195.26 1.50 12.72
ROE: -190.20 0.19 14.85

BRIEF-Cleveland Biolabs Reports Quarterly Loss Per Share Of $0.11

* CLEVELAND BIOLABS INC - REVENUE FOR Q1 OF 2018 DECREASED TO $0.2 MILLION COMPARED TO $0.6 MILLION FOR Q1 OF 2017

May 15 2018

BRIEF-Cleveland Biolabs Says Received Formal Notification From EMA

* CLEVELAND BIOLABS - RECEIVED DAY 120 REVIEW QUESTIONS FROM EMA REGARDING MARKETING AUTHORIZATION APPLICATION FOR ENTOLIMOD

Mar 28 2018

Earnings vs. Estimates